Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.

MLA

Grimison, P., et al. “Oral THC:CBD Cannabis Extract for Refractory Chemotherapy-Induced Nausea and Vomiting: A Randomised, Placebo-Controlled, Phase II Crossover Trial.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 31, no. 11, Nov. 2020, pp. 1553–60. EBSCOhost, https://doi.org/10.1016/j.annonc.2020.07.020.

APA

Grimison, P., Mersiades, A., Kirby, A., Lintzeris, N., Morton, R., Haber, P., Olver, I., Walsh, A., McGregor, I., Cheung, Y., Tognela, A., Hahn, C., Briscoe, K., Aghmesheh, M., Fox, P., Abdi, E., Clarke, S., Della-Fiorentina, S., Shannon, J., … Stockler, M. (2020). Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 31(11), 1553–1560. https://doi.org/10.1016/j.annonc.2020.07.020

Chicago

Grimison, P, A Mersiades, A Kirby, N Lintzeris, R Morton, P Haber, I Olver, et al. 2020. “Oral THC:CBD Cannabis Extract for Refractory Chemotherapy-Induced Nausea and Vomiting: A Randomised, Placebo-Controlled, Phase II Crossover Trial.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 31 (11): 1553–60. doi:10.1016/j.annonc.2020.07.020.